Projeto

New antitumor and antiangiogenic heterocyclic compounds: synthesis, molecular modeling, screening of enzymatic inhibition and studies in tumor and endothelial cell lines with tyrosine kinase membrane receptors as targets

Registo fonte
Referência: PTDC/QUI-QUI/111060/2009
Programa de financiamento: 5876-PPCDTI
Organização financiadora: Fundação para a Ciência e a Tecnologia
Instituições associadas: Instituto Politécnico de Bragança
Funding.name_str 5876-PPCDTI
MonetaryGrant.funder.alternateName_str_mv FCT
MonetaryGrant.funder.identifier_str_mv http://doi.org/10.13039/501100001871
MonetaryGrant.funder.name_str Fundação para a Ciência e a Tecnologia
ResearchProject.award.identifier_str PTDC/QUI-QUI/111060/2009
ResearchProject.award.name_str New antitumor and antiangiogenic heterocyclic compounds: synthesis, molecular modeling, screening of enzymatic inhibition and studies in tumor and endothelial cell lines with tyrosine kinase membrane receptors as targets
ResearchProject.award.url_str info:eu-repo/grantAgreement/FCT/5876-PPCDTI/PTDC%2FQUI-QUI%2F111060%2F2009/PT
_version_ 1869469558348185601
country_str PT
dirty 0
id ipb_ce4c46a02bc6ec2fc09dadadc2c2bb95#__funding__1
instacron_str ipb
institution Instituto Politécnico de Bragança
instname_str Instituto Politécnico de Bragança
network_acronym_str ipb
network_name_str Biblioteca Digital do IPB
oai_identifier_str oai:bibliotecadigital.ipb.pt:10198/9177
organization_str_mv http://doi.org/10.13039/501100001871
reponame_str Biblioteca Digital do IPB
semanticIdentifier_str_mv 10.13039/501100001871/5876-PPCDTI/PTDC/QUI-QUI/111060/2009
source_str http://hdl.handle.net/10198/9177
spellingShingle New antitumor and antiangiogenic heterocyclic compounds: synthesis, molecular modeling, screening of enzymatic inhibition and studies in tumor and endothelial cell lines with tyrosine kinase membrane receptors as targets
status CANONICAL
title New antitumor and antiangiogenic heterocyclic compounds: synthesis, molecular modeling, screening of enzymatic inhibition and studies in tumor and endothelial cell lines with tyrosine kinase membrane receptors as targets
title_sort New antitumor and antiangiogenic heterocyclic compounds: synthesis, molecular modeling, screening of enzymatic inhibition and studies in tumor and endothelial cell lines with tyrosine kinase membrane receptors as targets
visible 1

Publicações relacionadas

Carregando publicações...